AAAAAA
Results:
1-8
|
Results: 8
Authors:
DENIZOT Y
LORGEOT V
CORNU E
NATHAN N
Citation: Y. Denizot et al., PLASMA LEUKEMIA INHIBITORY FACTOR, INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR LEVELS DURING CARDIOPULMONARY BYPASS WITH EXTRACORPOREAL-CIRCULATION, Cytokine, 10(4), 1998, pp. 303-306
Authors:
COMTE L
LORGEOT V
BIGNON J
VOLKOV L
DUPUIS F
WDZIECZAKBAKALA J
PRALORAN V
Citation: L. Comte et al., IN-VIVO MODIFICATIONS OF ACSDKP METABOLISM AND HEMATOPOIESIS IN MICE TREATED WITH 5-FLUOROURACIL AND GORALATIDE, European journal of clinical investigation, 28(10), 1998, pp. 856-863
Authors:
LORGEOT V
TRIMOREAU F
GACHARD N
PRALORAN V
DENIZOT Y
Citation: V. Lorgeot et al., LEUKEMIA INHIBITORY FACTOR CONCENTRATIONS IN THE BONE-MARROW PLASMA OF HEALTHY-SUBJECTS AND PATIENTS WITH HEMATOLOGIC MALIGNANCIES, European cytokine network, 8(1), 1997, pp. 57-59
SPONTANEOUS AND INDUCIBLE PRODUCTION OF LEUKEMIA INHIBITORY FACTOR BYHUMAN BONE-MARROW STROMAL CELLS
Authors:
LORGEOT V
ROUGIER F
FIXE P
CORNU E
PRALORAN V
DENIZOT Y
Citation: V. Lorgeot et al., SPONTANEOUS AND INDUCIBLE PRODUCTION OF LEUKEMIA INHIBITORY FACTOR BYHUMAN BONE-MARROW STROMAL CELLS, Cytokine, 9(10), 1997, pp. 754-758
Authors:
LORGEOT V
PRALORAN V
TURLURE P
DENIZOT Y
Citation: V. Lorgeot et al., CONCENTRATIONS OF SERUM LEUKEMIA INHIBITORY FACTOR (LIF) IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Leukemia, 11(2), 1997, pp. 311-312
Authors:
COMTE L
LORGEOT V
VOLKOV L
ROULLET B
TUBIANA N
PRALORAN V
Citation: L. Comte et al., ACSDKP PLASMA-CONCENTRATIONS IN PATIENTS WITH SOLID TUMORS - COMPARISON OF 2 CHEMOTHERAPEUTIC REGIMENS, Cancer letters, 112(1), 1997, pp. 1-4
Authors:
COMTE L
LORGEOT V
VOLKOV L
ALLEGRAUD A
ALDIGIER JC
PRALORAN V
Citation: L. Comte et al., EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ENALAPRIL ON BLOOD HEMATOPOIETIC PROGENITORS AND ACETYL-N-SER-ASP-LYS-PRO CONCENTRATIONS, European journal of clinical investigation, 27(9), 1997, pp. 788-790
Authors:
FIXE P
LORGEOT V
LEMEUR Y
COUPEY L
HEYMANN D
GODARD A
PRALORAN V
Citation: P. Fixe et al., DEVELOPMENT OF ENZYMO-IMMUNOASSAYS (EIA) FOR MACROPHAGE-COLONY-STIMULATING FACTOR (M-CSF) AND LEUKEMIA INHIBITORY FACTOR (LIF) BY USING THESAME CAPTURE AND SIGNAL GENERATING POLYCLONAL ANTIBODY, Cytokine, 8(7), 1996, pp. 586-591
Risultati:
1-8
|